Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Food Scene
Community Directory
Community Service
Restaurant Guide
Rescue Me
Other
Specials
Entertainment Now
Spring Wellness
Home & Garden
Home Improvement
Home & Realty
Horizons
Outdoor Guide
Progress
Women
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
2022 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Crispr Therapeutics Ag
(NQ:
CRSP
)
50.47
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 26, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
48
Open
50.47
Bid (Size)
48.01 (5)
Ask (Size)
54.14 (1)
Prev. Close
50.47
Today's Range
50.47 - 50.47
52wk Range
38.94 - 86.95
Shares Outstanding
78,294,139
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
3 Gene Editing Stocks to Buy Now OR You’ll Be Kicking Yourself Later
January 25, 2023
Even in a risk-off market, gene editing stocks look attractive. Here are three stocks that may be worth a closer look at this time.
Via
InvestorPlace
3 Gene Editing Stocks With the Best Long-Term Potential
January 25, 2023
These gene editing stocks are likely to deliver massive gains ahead in the fast-evolving biotech space
Via
InvestorPlace
Performance
YTD
+23.10%
+23.10%
1 Month
+23.07%
+23.07%
3 Month
-3.61%
-3.61%
6 Month
-33.50%
-33.50%
1 Year
-18.39%
-18.39%
More News
Read More
Better Biotech Buy: Bluebird Bio or CRISPR Therapeutics?
January 22, 2023
Via
The Motley Fool
3 Smart Stocks to Buy if a Recession Is on the Way
January 21, 2023
Via
The Motley Fool
CRISPR Therapeutics Stock: Bull vs. Bear
January 19, 2023
Via
The Motley Fool
7 Biotech Stocks That Will Make You Rich in 10 Years
January 18, 2023
Via
InvestorPlace
5 Reasons to Buy Vertex Pharmaceuticals Now
January 18, 2023
Via
The Motley Fool
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
January 14, 2023
Via
The Motley Fool
3 CRISPR Stocks That Will Make You Filthy Rich in 10 Years
January 18, 2023
Via
InvestorPlace
2 Stocks Down More Than 25% to Buy Right Now
January 16, 2023
Via
The Motley Fool
5 Potentially Explosive Stocks to Buy in 2023
January 13, 2023
Via
The Motley Fool
More Likely to 5X First: CRISPR Therapeutics vs. InMode
January 12, 2023
Via
The Motley Fool
2 Growth Stocks You May Regret not Buying Right Now
January 11, 2023
Via
The Motley Fool
Can Cathie Wood Bounce Back in 2023?
January 11, 2023
Via
The Motley Fool
Expert Ratings for CRISPR Therapeutics
January 05, 2023
Via
Benzinga
2 Supercharged Stocks to Buy Right Now That Could Soar in 2023
January 11, 2023
Via
The Motley Fool
2 Risky Cathie Wood Stocks to Buy Today And Hold For 5 Years
January 07, 2023
Via
The Motley Fool
2 Under-the-Radar Biotech Stocks to Buy in 2023
January 06, 2023
Via
The Motley Fool
CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks
January 06, 2023
Via
Investor's Business Daily
Cathie Wood Gets Elon Musk's Attention Over Gene-Editing Therapy Potential: 'Investors Chased The Dream Then. Now, They're Running Away'
January 04, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via
Benzinga
Cathie Wood Is Buying These Top Growth Stocks -- and Both Could Make You Rich Over Time
January 04, 2023
Via
The Motley Fool
3 Growth Stocks That Could Skyrocket 50% or More In 2023, According to Wall Street
December 31, 2022
Via
The Motley Fool
1 Cathie Wood Stock to Buy While It's Affordable, and 1 to Avoid (for Now)
December 30, 2022
Via
The Motley Fool
2 Cathie Wood Stocks to Buy and Hold Through 2023 and Beyond
December 29, 2022
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
